A phase I study analysing AntiCD19 CAR-T Cells in relapsed and refractory (r/r) B cell lymphoma
Latest Information Update: 28 Jan 2022
At a glance
- Drugs MB CART19.1 (Primary) ; Cyclophosphamide; Fludarabine
- Indications B-cell lymphoma; Burkitt's lymphoma; Diffuse large B cell lymphoma; Follicular lymphoma; Mantle-cell lymphoma; Marginal zone B-cell lymphoma
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 28 Jan 2022 New trial record
- 14 Dec 2021 Final Results presented at the 63rd American Society of Hematology Annual Meeting and Exposition